On the release of glutamate and aspartate in the basal ganglia of the rat: Interactions with monoamines and neuropeptides

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 4, 1997, Pages 489-495

  Herrera Marschitz, M ^a   Goiny, M ^a   You, Z B ^a   Meana, J J ^a   Pettersson, E ^a   Rodriguez Puertas, R ^a   Xu, Z Q ^a   Terenius, L ^a   Hokfelt T ^a   Ungerstedt, U ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alzheimer's disease; Amino acids; Excitatory; Immunocytochemistry; In vivo; Microdialysis; Monoamines; Neuropeptides; Parkinson's disease; Psychosis; Rat

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; ASPARTIC ACID; CHOLECYSTOKININ; DOPAMINE; DYNORPHIN B; GLUTAMIC ACID; HOMOVANILLIC ACID; MONOAMINE; NEUROPEPTIDE; TETRODOTOXIN;

ALZHEIMER DISEASE; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN LEVEL; IMMUNOHISTOCHEMISTRY; NEOSTRIATUM; NERVE DEGENERATION; NEUROTRANSMITTER RELEASE; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; SUBSTANTIA NIGRA;

ANIMALS; ASPARTIC ACID; BASAL GANGLIA; BIOGENIC MONOAMINES; GLUTAMIC ACID; NEUROPEPTIDES; RATS;

EID: 0030969959     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(96)00033-4     Document Type: Article

References (73)

1. 1. Beresford, I. J. M.; Hall, M. D.; Clark, C. P.; Hill, R. I.; Sirinathsinghi, D. J. S., Striatal lesions and transplants demonstrate that CCK receptors are localized on intrinsic striatal neurones: a quantitative autoradiographic study. Neuropeptides, 10, 109-136 1987.
2. 2. Bridges, R.; Stanley, M. S.; Anderson, M. W.; Cotman, C. W.; Chamberlin, R., Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem., 34, 717-725 1991.
3. 3. Bustos, G.; Abarca, J.; Forray, M. I.; Gysling, K.; Bradberry, C. W.; Roth, R. H., Regulation of excitatory amino acid release by N-methyl-D-aspartate receptors in rat striatum: in vivo microdialysis studies. Brain Res., 585, 105-115 1992.
4. 4. Chang, R. S. L.; Lotti, V. J., Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystochinin antagonist. Proc. Natn. Acad. Sci. USA, 83, 4923-4926 1986.
5. 5. Christensson-Nylander, I.; Herrera-Marschitz, M.; Staines, W.; Hökfelt, T.; Terenius, L.; Ungerstedt, U.; Cuello, A. C.; Oertel, W. L.; Goldstein, M., Striato-nigral dynorphin and substance P pathways in the rat: I. Biochemical and immunohistochemical studies. Exp. Brain Res., 64, 169-192 1986.
6. 6. Clark, J. A.; Amara, S. G., Amino acid neurotransmitter transporters: structure, function, and molecular diversity. Bio Assays, 15, 323-332 1993.
7. 7. Cooke, J. D.; Quastel, D. M. J., The specific effect of potassium on transmitter release by motor nerve terminals and its inhibition by calcium. J. Physiol., 228, 435-458 1973.
8. 8. Di Chiara, G., In-vivo brain dialysis of neurotransmitters. Trends Pharmacol. Sci., 11, 116-121 1990.
9. 9. Dinopoulos, A.; Dori, I.; Parnavelas, J. G., Immunohistochemical localization of aspartate in corticofugal pathways. Neurosci. Lett., 121, 25-28 1991.
10. 10. Druce, D.; Peterson, D.; DeBelleroche, J.; Bradford, H. F., Differential amino acid neurotransmitter release in rat neostriatum following lesions of corticostriatal pathway. Brain Res., 247, 303-307 1982.
11. 11. Erecin'ska, M., The neurotransmitter amino acid transport systems. A fresh outlook on an old problem. Biochem. Pharmacol., 36, 3547-3555 1987.
12. 12. Fonnum, F., Glutamate: a neurotransmitter in mammalian brain. J. Neurochem., 42, 1-11 1984.
13. 13. Gaudreau, P.; Quirion, R.; St. Pierre, S.; Cjeuh, C. C.; Pert, A., Localization of CCK receptors in relation to the nigro-striatal and mesolimbic dopaminergic pathways. Neuropeptides, 9, 283-293 1987.
14. 2 dopamine receptor-regulated gene expression of striato-nigral and striato-pallidal neurons. Science, 250, 1429-1432 1990.
15. 15. Girault, J. A.; Barbeito, L.; Spampinato, U.; Gozlan, H.; Glowinski, J.; Besson, M. J., In vivo release of endogenous amino acids from the rat striatum: further evidence for a role of glutamate and aspartate in corticostriatal neurotransmision. J. Neurochem., 47, 98-106 1986.
16. 16. Godukhin, O.; You, Z.-B.; Herrera-Marschitz, M.; Goiny, M.; Petterson, E.; Hökfelt, T.; Ungerstedt, U., Effect of local cholecystokinin-8 administration on extracellular levels of amino acids and glycolytic products monitored by in vivo microdialysis in the frontoparietal cortex of the rat. Neurosci. Lett., 194, 29-32 1995.
17. 17. Grasso, A.; Alemà, S.; Rufini, S.; Senni, M. I., Black widow spider toxin-induced calcium fluxes and transmitter release in a neurosecretory cell line. Nature, 283, 775-776 1980.
18. 18. Hepler, J. R.; Toomin, C. S.; McCarthy, K. D.; Conti, F.; Battaglia, G.; Rustioni, A.; Petrusz, P. C., Characterization of antisera to glutamate and aspartate. J. Histochem., 36, 13-22 1988.
19. 19. Herrera-Marschitz, M.; Goiny, M.; Meana, J. J.; Silveira, R.; Godukhin, O.; Chen, Y.; Espinoza, S.; Pettersson, E.; Loidl, F.; Lubec, G.; Andersson, K.; Nylander, I.; Terenius, L.; Ungerstedt, U., On the origin of extracellular glutamate levels monitored in the basal ganglia by in vivo microdialysis. J. Neurochem., 66, 1726-1735 1996.
20. 20. Herrera-Marschitz, M.; Goiny, M.; Utsumi, H.; Ungerstedt, U., Mesencephalic dopamine innervation of the frontoparietal (sensori-motor) cortex of the rat: a microdialysis study. Neurosci. Lett., 97, 266-270 1989.
21. 21. Herrera-Marschitz, M.; Meana, J. J.; Hökfelt, T.; You, Z.-B.; Morino, P.; Brodin, E.; Ungerstedt, U., Cholecystokinin is released from a crossed corticostriatal pathway. Neuro Report, 3, 905-908 1992.
22. 22. Herrera-Marschitz, M.; Utsumi, H.; Ungerstedt, U., Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation. J. Neurol. Neurosurg. Psychiat., 53, 39-43 1990.
23. 23. Herrera-Marschitz, M.; You, Z.-B.; Meana, J. J.; O'Connor, W. T.; Goiny, M.; Reid, M. S.; Ungerstedt, U., Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions. Amino Acids, 2, 157-179 1992.
24. 24. Hill, D. R.; Campbell, N. J.; Shaw, T. M.; Woodruff, G. N., Autoradiographic localization and biochemical characterization of peripheral type of CCK receptors in rat CNS using selective nonpeptide CCK antagonists. J. Neurosci., 7, 2967-2977 1987.
25. 25. Hökfelt, T.; Mårtensson, R.; Björklund, A.; Kleinau, S.; Goldstein M. Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. In: Björklund, A.; Hökfelt T., eds. Handbook of chemical neuroanatomy, Vol. 2, Part I. New York: Elsevier Science; 1984:277-379.
26. 26. Iwata, H.; Koyama, Y.; Baba, A., Depolarization increases chloride-dependent glutamate sequestration in synaptic membranes of rat cerebral cortex. J. Neurochem., 52, 354-359 1989.
27. 27. Janson, A. M.; Meana, J. J.; Goiny, M.; Herrera-Marschitz, M., Chronic nicotine treatment counteracts the decreases in extracellular neostriatal dopamine induced by a unilateral transection at the mesodiencephalic junction in rats: a microdialysis study. Neurosci. Lett., 134, 88-92 1991.
28. 28. Johnston, G. A. R.; Sue, M.; Kennedy, E.; Twitchin, B., Action of the neurotoxin kainic acid on high affinity uptake of L-glutamic acid in rat brain slices. J. Neurochem., 32, 121-127 1979.
29. 29. Kanai, Y.; Hediger, M. A., Primary structure and functional characterization of a high-affinity glutamate transporter. Nature, 360, 467-476 1992.
30. 30. Kanner, B. I., Bioenergetics of neurotransmitter transport. Biochim. Biophys. Acta, 726, 293-316 1983.
31. 31. Lindefors, N.; Amberg, G.; Ungerstedt, U., Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Meth., 22, 141-156 1989.
32. 32. Lindroth, P.; Mopper, K., High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phtaldialdehyde. Anal. Chem., 51, 1667-1674 1979.
33. B) ligand: L-365,260. Eur. J. Pharmacol., 162, 273-280 1989.
34. 34. Mansour, A.; Meador-Woodruff, J. H.; Zhou, Q.; Civelli, O.; Akil, H.; Watson, S. J., A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiography and in situ hybridization techniques. Neuroscience, 46, 959-971 1992.
35. 35. Maura, G.; Carbone, R.; Raiteri, M., Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release. J. Pharmacol. Exp. Ther., 251, 1142-1146 1989.
36. 36. Maysinger, D.; Herrera-Marschitz, M.; Carlsson, A.; Garofalo, L.; Cuello, A. C.; Ungerstedt, U., Striatal and cortical acetylcholine release in vivo in rats with unilateral decortication: effects of treatment with monosialoganglioside GM1. Brain Res., 461, 355-360 1988.
37. 37. Meana, J. J.; Herrera-Marschitz, M.; Brodin, E.; Hökfelt, T.; Ungerstedt, U., Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis. Amino Acids, 1, 365-373 1991.
38. 38. Meana, J. J.; Johansson, B.; Herrera-Marschitz, M.; O'Connor, W. T.; Goiny, M.; Parkinson, F. E.; Fredholm, B. B.; Ungerstedt, U., Effect of the neurotoxin AF64A on intrinsic and extrinsic neuronal systems of the rat neostriatum measured by in vivo microdialysis. Brain Res., 596, 65-72 1992.
39. 39. Meldolesi, J.; Scheer, H.; Madeddu, L.; Wanke, E., Mechanism of action of α-latrotoxin: the presynaptic stimulatory toxin of the black widow spider venom. Trends Pharmacol. Sci., 7, 151-155 1986.
40. 40. Morino, P.; Herrera-Marschitz, M.; Castel, M. N.; Ungerstedt, U.; Varro, A.; Dockray, G.; Hökfelt, T., Cholecystokinin in cortico-striatal neurons in the rat: immunohistochemical studies at the light and electron microscopical level. Eur. J. Neurosci., 6, 681-692 1994.
41. 41. Morino, P.; Herrera-Marschitz, M.; Meana, J. J.; Ungerstedt, U.; Hökfelt, T., Immunohistochemical evidence for a crossed cholecystokinin corticostriatal pathway in the rat. Neurosci. Lett., 148, 132-136 1992.
42. 42. Narahashi, T., Chemical tools in the study of excitable membranes. Physiol. Rev., 54, 813-889 1974.
43. 43. Nicholls, D. G.; Attwell, D., The release and uptake of excitatory amino acids. Trends Pharmacol. Sci., 11, 462-468 1990.
44. 44. Ottersen, O. P.; Storm-Mathisen, J., Glutamate-and GABA-containing neurons in the mouse and rat brain as demonstrated with a new immunohistochemical technique. J. Comp. Neurol., 229, 374-392 1984.
45. 45. Ottersen, O. P.; Storm-Mathisen, J., Localization of amino acid neurotransmitters by immunocytochemistry. Trends Neurosci., 10, 250-254 1987.
46. 46. Palmer, A. M.; Huston, P. H.; Lowe, S. L.; Bowen, D. M., Extracellular connections of aspartate and glutamate in rat neostriatum following stimulation of frontal cortex. Exp. Brain Res., 75, 659-663 1989.
47. 47. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates. New York: Academic Press; 1982.
48. 48. Petrenko, A. G., α-Latrotoxin receptor. Implications in nerve terminal function. FEBS Lett., 325, 81-85 1993.
49. 1-subtype of receptor. Neuroscience, 74, 51-66 1996.
50. 50. Pines, G.; Danbolt, N. C.; Björås, M.; Zhang, Y.; Berdahan, A.; Eide, L.; Koepsell, H.; Storm-Mathisen, J.; Seeberg, E.; Kanner, D. I., Cloning and expression of a rat brain L-glutamate transporter. Nature, 360, 464-467 1992.
51. 3H SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine. Life Sci., 39, 321-328 1980.
52. 3H]glutamate transport activity: pharmacologic specificity and regulation by sodium and potassium. J. Neurochem., 60, 167-179 1993.
53. 53. Sandberg, M.; Ward, H. K.; Bradford, H. F., Effect of striate pathway lesion on the activities and metabolism of amino acid neurotransmitters in the striatum. J. Neurochem., 44, 42-47 1985.
54. 3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra. Neurosci. Lett., 72, 265-271 1986.
55. 55. Schousboe, A.; Westergaard, N.; Hertz, L., Neuronal-astrocytic interactions in glutamate metabolism. Biochem. Soc. Trans., 21, 49-52 1993.
56. 56. Semba, J.; Kito, S.; Toru, M., Characterisation of extracellular amino acids in striatum of freely moving rats by in vivo microdialysis. J Neural Transm., 100, 39-52 1995.
57. 57. Setler, P. E.; Sarau, H. M.; Zinke, C. L.; Sanders, H. L., The central effect of a novel dopamine agonist. Eur. J. Pharmacol., 50, 419-422 1978.
58. +-dependent glutamate/aspartate transporter from rat brain. Proc. Natn. Acad. Sci. USA, 891, 10955-10959 1992.
59. 59. Tossman, U.; Segovia, J.; Ungerstedt, U., Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis. Acta Physiol. Scand., 127, 547-556 1986.
60. 60. Tsumoto, T., Excitatory amino acid transmitters and their receptors in neural circuits of the cerebral neocortex. Neurosci. Res., 9, 79-102 1990.
61. 2-dopamine receptor. Nature, 292, 463-465 1981.
62. 62. Ungerstedt, U. Measurement of neurotransmitter release by intracranial microdialysis. In: Marsden, C. A., ed. Measurement of neurotransmitter release In vivo. Chichester: Wiley; 1984:81-105.
63. 63. Ungerstedt, U.; Herrera-Marschitz, M.; Jungnelius, U.; Ståhle, L.; Tossman, U.; Zetterström, T., Dopamine synaptic mechanisms reflected in studies combining behavioral recordings and brain dialysis. Adv. Biosci., 37, 219-231 1982.
64. 64. Vincent, S. R.; Hökfelt, T.; Christensson, I.; Terenius, L., Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. Eur. J. Pharmacol., 85, 2451-2452 1982.
65. 65. Westerink, B. H. C.; Damsma, G.; Rollema, H.; De Vries, J. B.; Horn, A. S., Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems. Life Sci., 41, 1763-1776 1987.
66. 66. Westerink, B. H. C.; Hofsteede, H. M.; Damsma, G.; De Vries, J. B., The significance of extracellular calcium for the release of dopamine, acetylcholine and amino acids in conscious rats, evaluated by brain microdialysis. Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 373-378 1988.
67. 67. Westerink, B. H. C.; Tuntler, J.; Damsma, G.; Rollema, H.; De Vries, J. B., The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 502-507 1987.
68. 68. You, Z.-B.; Herrera-Marschitz, M.; Brodin, E.; Meana, J. J.; Morino, P.; Hökfelt, T.; Silveira, R.; Goiny, M.; Ungerstedt, U., On the origin of striatal cholecystokinin release: studies with in vivo microdialysis. J. Neurochem., 62, 76-85 1994.
69. 2 receptor agonists. Neuroscience, 63, 427-434 1994.
70. 70. You, Z.-B.; Herrera-Marschitz, M.; Pettersson, E.; Nylander, I.; Goiny, M.; Shou, H.-Z.; Godukhin, O.; Hökfelt, T.; Terenius, L., Modulation of neurotransmitter release by cholecystokinin in neostriatum and substantia nigra of the rat: regional and receptor specificity. Neuroscience, 74, 793-804 1996.
71. +-depolarization, lesions and peptidase inhibition. Neuroscience, 63, 415-425 1994.
72. 72. You, Z.-B.; Pettersson, E.; Herrera-Marschitz, M.; Hökfelt, T.; Terenius, L.; Nylander, I.; Goiny, M.; Hughes, J.; O'Connor, W. T.; Ungerstedt, U., Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis. Neuro Report, 5, 2301-2304 1994.
73. 73. Zetterström, T.; Herrera-Marschitz, M.; Ungerstedt, U., Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res., 376, 1-7 1986.